Literature DB >> 16142497

[Palmoplantar erythrodysesthesia after intravenous therapy with docetaxel].

S Meller1, J Reifenberger, H Stege, T Ruzicka, B Homey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16142497     DOI： 10.1007/s00105-005-1024-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  10 in total

1.  Cutaneous hand and foot toxicity associated with cancer chemotherapy.

Authors:  June Childress; Jake Lokich
Journal:  Am J Clin Oncol       Date:  2003-10       Impact factor: 2.339

2.  A variant of the chemotherapy-associated erythrodysesthesia syndrome related to high-dose cyclophosphamide.

Authors:  J R Matsuyama; K K Kwok
Journal:  DICP       Date:  1989-10

3.  Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.

Authors:  Dorothee Eich; Karin Scharffetter-Kochanek; Hans Theodor Eich; Iliana Tantcheva-Poor; Thomas Krieg
Journal:  Am J Clin Oncol       Date:  2002-12       Impact factor: 2.339

4.  Fluorouracil and palmar-plantar erythrodysesthesia.

Authors:  C F Curran; J K Luce
Journal:  Ann Intern Med       Date:  1989-11-15       Impact factor: 25.391

5.  Prevention of docetaxel-induced erythrodysesthesia with local hypothermia.

Authors:  G C Zimmerman; J H Keeling; M Lowry; J Medina; D D Von Hoff; H A Burris
Journal:  J Natl Cancer Inst       Date:  1994-04-06       Impact factor: 13.506

6.  Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere.

Authors:  S J Vukelja; W J Baker; H A Burris; J H Keeling; D Von Hoff
Journal:  J Natl Cancer Inst       Date:  1993-09-01       Impact factor: 13.506

7.  Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia.

Authors:  W H Burgdorf; W A Gilmore; R G Ganick
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

8.  Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.

Authors:  C Y Chu; C H Yang; C Y Yang; G H Hsiao; H C Chiu
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

Review 9.  Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management.

Authors:  E Nagore; A Insa; O Sanmartín
Journal:  Am J Clin Dermatol       Date:  2000 Jul-Aug       Impact factor: 7.403

Review 10.  Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects.

Authors:  L C Pronk; G Stoter; J Verweij
Journal:  Cancer Treat Rev       Date:  1995-09       Impact factor: 12.111
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.